Psilocybin Microdosing: Trends, Research, and Legal Landscape in the USA

The growing interest in US psilocybin microdose capsules reflects a shift in mental health approaches. What is considered a dose of psilocybin? A typical microdose ranges from 0.1 mg to 0.3 mg of pure psilocybin, far below the full therapeutic dose used in clinical trials. Therapeutic use of psilocybin Current investigations suggest the potential of psilocybin microdoses in treating depression, with thousands treated with psilocybin reporting reduced anxiety. Regulatory landscape Is psilocybin legal in side effects of microdosing psilocybin the US? Legal status is state‑dependent, with Maryland and select regions moving toward de‑criminalization. Potential side effects are usually minimal, including headache. Scientific publications demonstrate differences across mushroom types. Global research contribute additional insight on treatment efficacy. News psilocybin this week underscore that controlled dosing is gaining traction across the US.